COCHLEAR DAMAGE AND INCREASED THRESHOLD IN ALPHA-DIFLUOROMETHYLORNITHINE (DFMO) TREATED GUINEA-PIGS

被引:20
作者
SALZER, SJ [1 ]
MATTOX, DE [1 ]
BROWNELL, WE [1 ]
机构
[1] JOHNS HOPKINS UNIV, SCH MED, DEPT OTOLARYNGOL HEAD & NECK SURG, BALTIMORE, MD 21205 USA
关键词
Alpha-difluoromethylornithine; Cochlea; DFMO; Hearing loss; Polyamine;
D O I
10.1016/0378-5955(90)90143-D
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Alpha-difluoromethylornithine (DFMO) inhibits polyamine synthesis and is used as an antineoplastic and antiparasitic drug. In early human trials DFMO unexpectedly caused a sensorineural hearing loss. In the current study DFMO was administered to guinea pigs to investigate its effects on organ of Corti histology and on auditory thresholds. Histologic examination revealed that DFMO caused greatest damage in the hook and first turn. Damage in the second and third turns was minimal. Animals treated for 12 weeks with DFMO differed significantly (P < 0.05) from controls in the hook and first turn in that: 1) DFMO caused a loss of hair cells in all rows. Loss of inner hair cells was greater than that of outer hair cells. 2) The remaining outer hair cells were shorter and contained a greater number of Hensen bodies. 3) The Deiters' cell bodies were longer and this increased length was associated with the decreased length of the corresponding outer hair cells. Brainstem audiometry showed that DFMO produced a hearing loss and the magnitude of this loss increased over twelve weeks of DFMO administration. © 1990.
引用
收藏
页码:101 / 112
页数:12
相关论文
共 37 条
[1]  
ABELOFF MD, 1986, CANCER TREAT REP, V70, P843
[2]   PHASE-I TRIAL AND PHARMACOKINETIC STUDIES OF ALPHA-DIFLUOROMETHYLORNITHINE - AN INHIBITOR OF POLYAMINE BIOSYNTHESIS [J].
ABELOFF, MD ;
SLAVIK, M ;
LUK, GD ;
GRIFFIN, CA ;
HERMANN, J ;
BLANC, O ;
SJOERDSMA, A ;
BAYLIN, SB .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (02) :124-130
[3]   EFFECTS OF THE ORNITHINE DECARBOXYLASE INHIBITORS DL-ALPHA-DIFLUOROMETHYLORNITHINE AND ALPHA-MONOFLUOROMETHYLDEHYDROORNITHINE METHYL-ESTER ALONE AND IN COMBINATION WITH SURAMIN AGAINST TRYPANOSOMA-BRUCEI-BRUCEI CENTRAL-NERVOUS-SYSTEM MODELS [J].
BACCHI, CJ ;
NATHAN, HC ;
CLARKSON, AB ;
BIENEN, EJ ;
BITONTI, AJ ;
MCCANN, PP ;
SJOERDSMA, A .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1987, 36 (01) :46-52
[4]  
Bachrach U., 1973, FUNCTION NATURALLY O
[5]  
Canellakis E S, 1979, Curr Top Cell Regul, V15, P155
[6]   NEW DRUG-COMBINATION FOR EXPERIMENTAL LATE-STAGE AFRICAN TRYPANOSOMIASIS - DL-ALPHA-DIFLUOROMETHYLORNITHINE (DFMO) WITH SURAMIN [J].
CLARKSON, AB ;
BIENEN, EJ ;
BACCHI, CJ ;
MCCANN, PP ;
NATHAN, HC ;
HUTNER, SH ;
SJOERDSMA, A .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1984, 33 (06) :1073-1077
[7]  
ENGSTROM H, 1960, Acta Otolaryngol Suppl, V158, P219
[8]  
HENLEY C, 1988, ABSTR ASS RES OT
[9]   INHIBITION OF INNER-EAR ORNITHINE DECARBOXYLASE BY NEOMYCIN INVITRO [J].
HENLEY, CM ;
GERHARDT, HJ ;
SCHACHT, J .
BRAIN RESEARCH BULLETIN, 1987, 19 (06) :695-698
[10]  
HERR HW, 1984, CANCER, V53, P1294, DOI 10.1002/1097-0142(19840315)53:6<1294::AID-CNCR2820530612>3.0.CO